Tag: generic drugs - Page 2
Biosimilar or Generic? How to Choose the Right Medication for Your Treatment
Learn the key differences between biosimilars and generic drugs to make informed treatment choices. Understand cost, safety, and when each option is right for you.
Paragraph IV Certifications: How Generic Drug Companies Challenge Patents Before Market Entry
Paragraph IV certifications let generic drugmakers challenge brand-name patents before launch, speeding up cheaper alternatives. This legal tool under the Hatch-Waxman Act has saved consumers trillions and reshaped pharmaceutical competition.
De Facto Combinations: Why Doctors Prescribe Separate Pills Instead of Fixed-Dose Combination Drugs
De facto combinations-taking separate generic pills instead of a single fixed-dose combination drug-are common but risky. Learn why doctors use them, when they make sense, and how to stay safe.
When Do Drug Patents Expire? Understanding the 20-Year Term and Real-World Timelines
Drug patents last 20 years from filing - but most drugs lose exclusivity after 7 to 14 years due to FDA review delays, patent extensions, and regulatory exclusivity. Learn how the real timeline works and why generics don't appear right away.
- 1
- 2
